DRAP seeks explanation from UHS VC
LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has sought explanation from the University of Health Sciences (UHS) vice chancellor for initiating clinical trials of vaccines without prior approval from Division of Pharmacy Services, DRAP.
In a note to UHS Vice Chancellor Prof Dr Javed Akram, DRAP said University of Health Sciences neither applied to Director Division of Pharmacy Services/Chairman Clinical Committee to conduct clinical trials of vaccines nor any clinical trials has been approved by the committee.
DRAP directed the UHS VC to stop clinical study on vaccines immediately and explain his position within three days for starting clinical trials without approval from the Clinical Study Committee, Division of Pharmacy Services, DRAP.
-
Jesy Nelson Reflects On Leaving Girls' Band Little Mix -
World’s First Pokemon Theme Park Opens In Tokyo, Boosts Japan Tourism -
Waymo Trains Robotaxis In Virtual Cities Using DeepMind’s Genie 3 -
5 Simple Rules To Follow For Smooth, Healthy Hair -
$44 Billion Bitcoin Blunder: Bithumb Exchange Apologizes For Accidental Payout -
Katie Price Ends Public Feud With Ex Peter Andre After 16 Years -
Apple May Bring ChatGPT And Other AI Apps To CarPlay -
Meghan Markle, Prince Harry Likely To Attend Super Bowl Halftime Show 2026 -
AI Next Big Trial: Elon Musk Calls For ‘Galileo Test’ To Prove True Intelligence -
US Appeals Court Affirms Trump’s Immigration Detention Policy -
Bella Hadid, Adan Banuelos Rekindle Romance After Brief Separation -
Jay-Z Shares Bold Advice With Bad Bunny For NFL Super Bowl Halftime Show Appearance -
Epstein Probe: Bill, Hillary Clinton Call For Public Testimony Hearing -
Brooklyn Beckham Considers Adoption As Nicola Peltz Can't Carry A Baby -
Expert Discusses 'complications' Of Measles Outbreak -
Kaley Cuoco Recalls Her Divorce With Karl Cook: 'I Was Gonna Die'